Neurology

AT J.P. MORGAN HEALTHCARE CONFERENCE, 120/80 GROUP PROJECTS ANOTHER YEAR OF RAPID GROWTH IN HELPING TO ACCELERATE THE CONVERGENCE OF AI AND HEALTHAT J.P. MORGAN HEALTHCARE CONFERENCE, 120/80 GROUP PROJECTS ANOTHER YEAR OF RAPID GROWTH IN HELPING TO ACCELERATE THE CONVERGENCE OF AI AND HEALTH

AT J.P. MORGAN HEALTHCARE CONFERENCE, 120/80 GROUP PROJECTS ANOTHER YEAR OF RAPID GROWTH IN HELPING TO ACCELERATE THE CONVERGENCE OF AI AND HEALTH

The Consultancy Announces Executive Hires, New Research and Conference Platforms Focused on Life Sciences and AI NEW YORK and SAN…

5 months ago
Ambience Healthcare and St. Luke’s Health System Partner to Reduce Clinician Burnout and Increase Patient Face TimeAmbience Healthcare and St. Luke’s Health System Partner to Reduce Clinician Burnout and Increase Patient Face Time

Ambience Healthcare and St. Luke’s Health System Partner to Reduce Clinician Burnout and Increase Patient Face Time

SAN FRANCISCO, CA / ACCESSWIRE / January 14, 2025 / Ambience Healthcare, the leading AI platform for healthcare documentation, scribing,…

5 months ago
PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other ConditionsPaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions

PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions

BOSTON, MA / ACCESSWIRE / January 14, 2025 / PaxMedica, Inc. (OTC PINK:PXMD), a clinical-stage biopharmaceutical company dedicated to advancing…

5 months ago
Vivalink Recognized with 2024 Global Healthcare IT Solutions Award by Frost & SullivanVivalink Recognized with 2024 Global Healthcare IT Solutions Award by Frost & Sullivan

Vivalink Recognized with 2024 Global Healthcare IT Solutions Award by Frost & Sullivan

Vivalink honored for enabling technology leadership with its innovative remote patient monitoring solutions CAMPBELL, Calif., Jan. 9, 2025 /PRNewswire/ --…

5 months ago
RyboDyn, Inc. Announces Discovery of a Cryptic Human Proteome and $4M Pre-Seed FinancingRyboDyn, Inc. Announces Discovery of a Cryptic Human Proteome and $4M Pre-Seed Financing

RyboDyn, Inc. Announces Discovery of a Cryptic Human Proteome and $4M Pre-Seed Financing

Dark genome biotech company RyboDyn closes pre-seed fundraise from leading global investors to advance cancer immunotherapy SAN DIEGO, Jan. 9,…

5 months ago
Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219’s Transformative Potential for CNS DisordersRapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219’s Transformative Potential for CNS Disorders

Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219’s Transformative Potential for CNS Disorders

In the PET trial, RAP-219 achieved and exceeded target receptor occupancy, increasing support for the dosing regimen utilized in the…

5 months ago
Hartford HealthCare and Aidoc Partner to Transform Patient Care with Enterprise AIHartford HealthCare and Aidoc Partner to Transform Patient Care with Enterprise AI

Hartford HealthCare and Aidoc Partner to Transform Patient Care with Enterprise AI

The partnership reached initial go-live in three weeks, showcasing the impressive speed and scalability of Aidoc's aiOS™ platform HARTFORD, Conn.,…

5 months ago
Tenvie Therapeutics Launches with $200 Million to Deliver Breakthrough Small Molecule TherapiesTenvie Therapeutics Launches with $200 Million to Deliver Breakthrough Small Molecule Therapies

Tenvie Therapeutics Launches with $200 Million to Deliver Breakthrough Small Molecule Therapies

Advancing a deep pipeline of therapeutics focused on treating neurological, cardiometabolic, and ophthalmic diseases Led by expert R&D leadership team…

5 months ago
Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287

Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287

BETHESDA, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology…

5 months ago